|
HU212435B
(en)
|
1990-06-07 |
1996-06-28 |
Sandoz Ag |
Herbicidal compositions containing substituted phthalides and heterocyclic phthalides as active ingredient and process for preparation of their active ingredients.
|
|
PT707567E
(pt)
|
1993-07-09 |
2002-01-30 |
Schering Corp |
Processo de sintese de azetidinonas
|
|
JPH08295646A
(ja)
|
1995-04-26 |
1996-11-12 |
Teijin Ltd |
ビス(ヒドロキシエトキシフェニル)化合物の製造方法
|
|
US6187774B1
(en)
|
1996-03-04 |
2001-02-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Fused heterocyclic compounds and pharmaceutical applications thereof
|
|
AU5907898A
(en)
|
1997-01-13 |
1998-08-03 |
Penn State Research Foundation, The |
Asymmetric synthesis and catalysis with chiral heterocyclic compounds
|
|
IT1292461B1
(it)
|
1997-07-03 |
1999-02-08 |
Great Lakes Chemical Italia |
Composti fotocromatici,procedimento per la loro preparazione e loro utilizzo in materiali polimerici
|
|
US6927214B1
(en)
|
1999-01-15 |
2005-08-09 |
Novo Nordisk A/S |
Non-peptide GLP-1 agonists
|
|
HK1051137A1
(zh)
|
1999-07-09 |
2003-07-25 |
Isis Innovation Limited |
抑制疾病的化合物和製備移植用的細胞
|
|
US7256201B2
(en)
|
2000-12-07 |
2007-08-14 |
Astrazeneca Ab |
Selective estrogen receptor-β ligands
|
|
BR0116468A
(pt)
|
2000-12-08 |
2004-06-29 |
Ortho Mcneil Pharm Inc |
Compostos de pirrolina substituìda por indazolila como inibidores de cinase
|
|
CA2450555A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
|
UA74912C2
(en)
*
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
US7192939B2
(en)
|
2002-01-30 |
2007-03-20 |
Montana State University |
Pestalotiopsis microsporia isolates and compounds derived therefrom
|
|
KR20050043967A
(ko)
|
2002-09-17 |
2005-05-11 |
액테리온 파마슈티칼 리미티드 |
1-피리딘-4-일-요소 유도체
|
|
WO2004107958A2
(en)
|
2003-05-30 |
2004-12-16 |
Schering Corporation |
Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
|
|
SG146683A1
(en)
|
2003-09-17 |
2008-10-30 |
Janssen Pharmaceutica Nv |
Fused heterocyclic compounds as serotonin receptor modulators
|
|
US7371759B2
(en)
|
2003-09-25 |
2008-05-13 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
WO2005066136A1
(en)
|
2003-12-22 |
2005-07-21 |
Eli Lilly And Company |
Bicyclic derivatives as ppar modulators
|
|
WO2005112932A2
(en)
|
2004-05-07 |
2005-12-01 |
Exelixis, Inc. |
Raf modulators and methods of use
|
|
US7569580B2
(en)
|
2004-06-03 |
2009-08-04 |
Rigel Pharmaceuticals, Inc. |
Heterotricyclic compounds for use as HCV inhibitors
|
|
GB0419481D0
(en)
|
2004-09-02 |
2004-10-06 |
Cancer Rec Tech Ltd |
Isoindolin-1-one derivatives
|
|
BRPI0515532A
(pt)
|
2004-09-21 |
2008-07-29 |
Athersys Inc |
composto, composição farmacêutica, métodos de inibir a ligação de ligandos endógenos ao receptor de crth-2 em uma célula, de tratar, melhorar ou prevenir um distúrbio responsivo à inibição da ligação de ligandos endógenos ao receptor de crt-2 e de preparar um composto, e, kit
|
|
EP2305246B1
(en)
|
2005-01-31 |
2015-08-26 |
The Trustees of the University of Pennsylvania |
Tumor necrosis factor inhibitors
|
|
JP2008536881A
(ja)
|
2005-04-21 |
2008-09-11 |
ガストロテック・ファルマ・アクティーゼルスカブ |
Glp−1分子と制吐剤との医薬製剤
|
|
AU2006271781A1
(en)
|
2005-07-15 |
2007-01-25 |
F. Hoffmann-La Roche Ag |
Novel heteroaryl fused cyclic amines
|
|
BRPI0616465A2
(pt)
|
2005-09-29 |
2011-06-21 |
Sanofi Aventis |
derivados de fenil-[1,2,4]-oxadiazol-5-ona com grupo fenila, bem como seu uso, composição farmacêutica compreendo os mesmos e processo de preparação da referida composição farmacêutica
|
|
BRPI0618523A2
(pt)
|
2005-11-11 |
2011-09-06 |
Hoffmann La Roche |
compostos de aminas cìclicas fundidas carbocìclicas, composições farmacêuticas e usos dos mesmos
|
|
BRPI0707718A2
(pt)
|
2006-02-10 |
2011-05-10 |
Summit Corp Plc |
uso de um composto
|
|
EP2046333A4
(en)
|
2006-07-24 |
2010-09-15 |
Glaxosmithkline Llc |
THIOZOLIDINEDIONE DERIVATIVES AS INHIBITORS OF P13-KINASE
|
|
AU2007315848A1
(en)
|
2006-11-03 |
2008-05-08 |
Glenmark Pharmaceuticals S.A. |
Bridged bicyclic indazoles as cannabinoid receptor ligands
|
|
EA200900821A1
(ru)
|
2006-12-22 |
2010-02-26 |
Новартис Аг |
Производные 1-аминометил-l-фенилциклогексана как ингибиторы дпп-iv (дипептидилпептидазы-iv)
|
|
GB0706072D0
(en)
|
2007-03-28 |
2007-05-09 |
Sterix Ltd |
Compound
|
|
WO2008130581A1
(en)
|
2007-04-20 |
2008-10-30 |
Schering Corporation |
Pyrimidinone derivatives and methods of use thereof
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
US20100292292A1
(en)
|
2007-09-13 |
2010-11-18 |
Link Medicine Corporation |
Treatment of Neurodegenerative Diseases Using Indatraline Analogs
|
|
CN101998959B
(zh)
|
2008-02-06 |
2013-08-28 |
生物马林药物股份有限公司 |
聚(adp-核糖)聚合酶(parp)的苯并噁唑甲酰胺抑制剂
|
|
AU2009233711B2
(en)
|
2008-04-09 |
2015-02-12 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
|
US8735391B2
(en)
|
2008-09-26 |
2014-05-27 |
University Of Kansas |
Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
|
|
EP2393810A1
(en)
|
2009-02-05 |
2011-12-14 |
Schering Corporation |
Phthalazine-containing antidiabetic compounds
|
|
US8455516B2
(en)
|
2010-01-15 |
2013-06-04 |
Touro University |
HIV-1 fusion inhibitors and methods
|
|
WO2011156655A2
(en)
|
2010-06-09 |
2011-12-15 |
Receptos, Inc. |
Novel glp-1 receptor stabilizers and modulators
|
|
WO2012065065A1
(en)
|
2010-11-12 |
2012-05-18 |
Follica, Inc. |
Methods and compositions for modulating hair growth, wound healing and scar revision
|
|
JP5770304B2
(ja)
|
2010-11-16 |
2015-08-26 |
ユニバーシティ・オブ・メディシン・アンド・デンティストリー・オブ・ニュージャージーUniversity Of Medicine Anddentistry Of New Jersey |
安全な化学的ミトコンドリア脱共役剤を用いたii型糖尿病及び糖尿病関連疾患の治療
|
|
JP5687120B2
(ja)
|
2011-04-20 |
2015-03-18 |
ユニチカ株式会社 |
ポリアリレート樹脂
|
|
JP5805982B2
(ja)
|
2011-04-20 |
2015-11-10 |
ユニチカ株式会社 |
ポリアリレート樹脂フィルムおよび気体分離膜
|
|
KR101401705B1
(ko)
|
2012-01-31 |
2014-06-27 |
울산대학교 산학협력단 |
로듐 촉매를 이용한 이소인돌린 유도체의 합성방법
|
|
US20150057243A1
(en)
|
2012-04-02 |
2015-02-26 |
Northern University |
Compositions and Methods for the Inhibition of Methyltransferases
|
|
WO2014055634A1
(en)
|
2012-10-02 |
2014-04-10 |
Yale University |
Identification of small molecule inhibitors of jumonji at-rich interactive domain 1a (jarid1a) and 1b (jarid1b) histone demethylase
|
|
WO2014101120A1
(en)
|
2012-12-28 |
2014-07-03 |
Merck Sharp & Dohme Corp. |
Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
|
|
JP6314335B2
(ja)
|
2013-02-06 |
2018-04-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新しいインダニルオキシジヒドロベンゾフラニル酢酸
|
|
TR201904614T4
(en)
|
2013-02-27 |
2019-05-21 |
Mochida Pharm Co Ltd |
Novel pyrazole derivative.
|
|
CN105377857B
(zh)
|
2013-07-17 |
2018-04-10 |
勃林格殷格翰国际有限公司 |
新颖氮杂苯并咪唑衍生物
|
|
CN103421006B
(zh)
|
2013-08-18 |
2016-06-22 |
上海师范大学 |
2,3,5,7-四取代二氢吡唑并六氢吡啶衍生物及其制备方法和应用
|
|
EP2857550A1
(en)
|
2013-10-02 |
2015-04-08 |
Basf Se |
Amine precursors for depositing graphene
|
|
PL3063139T3
(pl)
|
2013-10-29 |
2019-05-31 |
Takeda Pharmaceuticals Co |
Związek heterocykliczny
|
|
AR099936A1
(es)
|
2014-04-04 |
2016-08-31 |
Sanofi Sa |
Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados
|
|
EP2993174A1
(en)
|
2014-09-08 |
2016-03-09 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH |
Pyrazolopyridine derivatives and their use in therapy
|
|
CN105646459A
(zh)
|
2014-11-13 |
2016-06-08 |
上海和辉光电有限公司 |
一种化合物及其制备方法和应用
|
|
WO2016118639A1
(en)
|
2015-01-20 |
2016-07-28 |
The Trustees Of Columbia University In The City Of New York |
Small molecule oxidizers of pdi and their use
|
|
WO2017182983A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
WO2017182986A1
(en)
|
2016-04-22 |
2017-10-26 |
Sabic Global Technologies B.V. |
Methods of manufacture of 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
|
|
CN108884041A
(zh)
|
2016-04-22 |
2018-11-23 |
沙特基础工业全球技术有限公司 |
2-芳基-3,3-双(4-羟基芳基)苯并吡咯酮的制备方法,以及由其衍生的聚合物
|
|
JOP20190060A1
(ar)
*
|
2016-09-26 |
2019-03-26 |
Chugai Pharmaceutical Co Ltd |
مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
WO2018109607A1
(en)
|
2016-12-16 |
2018-06-21 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|
|
CN120267671A
(zh)
|
2017-03-31 |
2025-07-08 |
奥锐金肿瘤有限公司 |
用于治疗血液病的化合物和组合物
|
|
TWI782056B
(zh)
|
2017-07-14 |
2022-11-01 |
日商鹽野義製藥股份有限公司 |
具有mgat2抑制活性的縮合環衍生物
|
|
US11168079B2
(en)
|
2017-11-01 |
2021-11-09 |
Bristol-Myers Squibb Company |
Alkene compounds as farnesoid x receptor modulators
|
|
JP7461104B2
(ja)
*
|
2017-11-29 |
2024-04-03 |
中外製薬株式会社 |
Glp-1受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
|
|
MX2020006459A
(es)
|
2017-12-22 |
2020-11-06 |
Chemocentryx Inc |
Compuestos de anillos fusionados 6,5 diaril sustituidos como inhibidores de c5ar.
|
|
PE20211273A1
(es)
*
|
2018-02-01 |
2021-07-19 |
Japan Tobacco Inc |
Compuesto de amida heterociclica nitrogenada y su uso para fines medicos
|
|
CN112105357A
(zh)
|
2018-02-16 |
2020-12-18 |
Ucb生物制药有限责任公司 |
药用6,5杂双环衍生物
|
|
JP2021514982A
(ja)
*
|
2018-02-28 |
2021-06-17 |
ノバルティス アーゲー |
インドール−2−カルボニル化合物及びb型肝炎治療のためのそれらの使用
|
|
US20190284340A1
(en)
|
2018-03-14 |
2019-09-19 |
SABIC Global Technologies B.V |
3-oxo-2-arylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
US20190284341A1
(en)
|
2018-03-14 |
2019-09-19 |
Sabic Global Technologies B.V. |
3-oxo-2-alkylisoindoline diphthalonitrile monomers, methods of manufacture, thermosetting compositions comprising the same, and uses thereof
|
|
ES2993034T3
(en)
|
2018-04-02 |
2024-12-20 |
Chemocentryx Inc |
Prodrugs of fused-bicyclic c5ar antagonists
|
|
CA3045644C
(en)
|
2018-06-13 |
2024-01-16 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|
|
FI3806855T3
(fi)
|
2018-06-15 |
2023-05-04 |
Pfizer |
Glp-1 -reseptorin agonisteja ja niiden käyttöjä
|
|
WO2020001321A1
(en)
|
2018-06-27 |
2020-01-02 |
The Hong Kong Polytechnic University |
Compounds with antimicrobial activity
|
|
US11923622B2
(en)
|
2018-08-02 |
2024-03-05 |
Nokia Solutions And Networks Oy |
Antenna and wireless communication device
|
|
UY38434A
(es)
*
|
2018-11-02 |
2020-05-29 |
Aicuris Gmbh & Co Kg |
Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv)
|
|
AR116947A1
(es)
*
|
2018-11-02 |
2021-06-30 |
Aicuris Gmbh & Co Kg |
Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas-indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb)
|
|
EA202191432A1
(ru)
|
2018-11-22 |
2021-10-14 |
Цилу Регор Терапьютикс Инк. |
Агонисты glp-1r и их применения
|
|
CN111217796B
(zh)
|
2018-11-26 |
2021-12-14 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷/二吡咯甲川化合物及其制备方法和应用
|
|
CN111217842B
(zh)
|
2018-11-26 |
2023-01-31 |
上海亚舸生物科技有限公司 |
一类螺环-二吡咯甲烷硼配合物/二吡咯甲川硼配合物及其制备方法和应用
|
|
WO2020135513A1
(zh)
|
2018-12-25 |
2020-07-02 |
上海美悦生物科技发展有限公司 |
一种作为irak抑制剂的化合物
|
|
WO2020163236A1
(en)
|
2019-02-04 |
2020-08-13 |
The General Hospital Corporation |
Treating long qt syndrome
|
|
PH12021552191A1
(en)
|
2019-03-14 |
2022-08-15 |
Janssen Sciences Ireland Unlimited Co |
Fused ring pyrimidone derivatives for use in the treatment of hbv infection or of hbv-induced diseases
|
|
AU2020256647B2
(en)
|
2019-04-12 |
2025-07-31 |
Qilu Regor Therapeutics Inc. |
GLP-1R agonists and uses thereof
|
|
TWI751585B
(zh)
|
2019-06-28 |
2022-01-01 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2021018023A1
(zh)
|
2019-08-01 |
2021-02-04 |
济南泰达领创医药技术有限公司 |
小分子glp-1受体调节剂
|
|
CN110804059B
(zh)
|
2019-09-30 |
2024-03-12 |
郑州泰基鸿诺医药股份有限公司 |
氨基甲酸酯类化合物、药物组合物及其应用
|
|
CR20220178A
(es)
|
2019-10-25 |
2022-06-15 |
Gilead Sciences Inc |
Compuestos moduladores de glp-1r
|
|
ES3029360T3
(en)
|
2019-11-15 |
2025-06-24 |
Ildong Pharmaceutical Co Ltd |
Glp-1 receptor agonist and use thereof
|
|
PT4097099T
(pt)
|
2020-02-07 |
2024-07-19 |
Gasherbrum Bio Inc |
Agonistas heterocíclicos de glp-1
|
|
CN115697999A
(zh)
|
2020-02-13 |
2023-02-03 |
加舒布鲁姆生物公司 |
杂环glp-1激动剂
|
|
WO2021219019A1
(en)
|
2020-04-29 |
2021-11-04 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
KR20260040657A
(ko)
*
|
2020-07-20 |
2026-03-25 |
에코진 인크. |
테트라히드로피라졸로-피라지닐-디히드로이미다졸론 또는 테트라히드로피라졸로-피리디닐-디히드로이미다졸론 화합물 및 그의 사용 방법
|
|
US20230322771A1
(en)
|
2020-09-07 |
2023-10-12 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
WO2022053010A1
(en)
|
2020-09-11 |
2022-03-17 |
Janssen Sciences Ireland Unlimited Company |
Fused ring pyrimidone derivatives for use in the treatment of hbv infection or of hbv-induced diseases
|
|
US20240366639A1
(en)
|
2021-08-12 |
2024-11-07 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
EP4490155A1
(en)
|
2022-03-09 |
2025-01-15 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
CN121002014A
(zh)
|
2022-12-15 |
2025-11-21 |
加舒布鲁姆生物公司 |
具有glp-1激动剂活性的化合物的盐和固体形式
|
|
IL321472A
(en)
|
2022-12-19 |
2025-08-01 |
Lilly Co Eli |
Process for the production of GLP1 RA and intermediates therefor
|
|
US20260217707A1
(en)
|
2023-01-17 |
2026-07-30 |
Fochon Biosciences, Ltd. |
Glp-1r agonists and uses thereof
|
|
KR20250168210A
(ko)
|
2023-02-16 |
2025-12-02 |
가셔브룸 바이오, 인크. |
헤테로시클릭 glp-1 효능제
|
|
CN119630663B
(zh)
|
2023-06-29 |
2025-10-21 |
韦恩生物科技有限公司 |
一种glp-1受体激动剂及其制备方法和用途
|